BMP-6 is a key endogenous regulator of hepcidin expression and iron metabolism

By B. Andriopoulos, E. Corradini, Yin Xia, Sarah A. Faasse, Shanzhuo Chen, L. Grgurević, M. Knutson, A. Pietrangelo, S. Vukicevic, Herbert Y. Lin and 1 more. Nature Genetics, 2009

774 citations recorded by the source corpus.

Juvenile hemochromatosis is an iron-overload disorder caused by mutations in the genes encoding the major iron regulatory hormone hepcidin (HAMP) and hemojuvelin (HFE2). We have previously shown that hemojuvelin is a co-receptor for bone morphogenetic proteins (BMPs) and that BMP signals regulate hepcidin expression and iron metabolism. However, the endogenous BMP regulator(s) of hepcidin in vivo is unknown. Here we show that compared with soluble hemojuvelin (HJV.Fc), the homologous DRAGON.Fc is a more potent inhibitor of BMP2 or BMP4 but a less potent inhibitor of BMP6 in vitro. In vivo, HJV.Fc or a neutralizing antibody to BMP6 inhibits hepcidin expression and increases serum iron, whereas DRAGON.Fc has no effect. Notably, Bmp6-null mice have a phenotype resembling hereditary hemochromatosis, with reduced hepcidin expression and tissue iron overload. Finally, we demonstrate a physical interaction between HJV.Fc and BMP6, and we show that BMP6 increases hepcidin expression and reduces serum iron in mice. These data support a key role for BMP6 as a ligand for hemojuvelin and an endogenous regulator of hepcidin expression and iron metabolism in vivo.

Subfields: Hematology, Nutrition and Dietetics, Plant Science

View Paper: https://www.semanticscholar.org/paper/8c80bb9deb040f837beb928a9bd5dfd111d3bb69

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Hematology

  1. T. Ganz
  2. E. Nemeth

In Nutrition and Dietetics

  1. T. Ganz

Citations in the corpus